Spring 2013 issue (pdf) - Medical College of Wisconsin
Spring 2013 issue (pdf) - Medical College of Wisconsin
Spring 2013 issue (pdf) - Medical College of Wisconsin
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Researcher studies non-alcoholic fatty liver disease<br />
The National Institute <strong>of</strong> Diabetes<br />
and Digestive and Kidney Diseases has<br />
awarded a five-year,<br />
$7 million grant to a<br />
pediatric gastroenterology<br />
researcher<br />
to investigate the<br />
link between intestinal<br />
bacteria and<br />
non-alcoholic fatty<br />
liver disease<br />
(NAFLD). Nita H.<br />
Nita H. Salzman, MD,<br />
PhD<br />
Salzman, MD, PhD, Associate Pr<strong>of</strong>essor<br />
<strong>of</strong> Pediatrics (Gastroenterology) at MCW<br />
and a researcher at Children’s Hospital <strong>of</strong><br />
<strong>Wisconsin</strong> Research Institute, will collaborate<br />
as PI on the project with an<br />
investigator at Washington University<br />
School <strong>of</strong> Medicine in St. Louis.<br />
NAFLD occurs when excess fat has<br />
built up in liver cells due to causes other<br />
than alcohol. This disease may affect up<br />
to one third <strong>of</strong> Americans. NAFLD can<br />
progress into non-alcoholic steatohepatitis,<br />
in which the liver is inflamed and<br />
may ultimately develop cirrhosis.<br />
Recent evidence has demonstrated a<br />
link between obesity, NAFLD and the<br />
makeup <strong>of</strong> the intestinal microbiome, a<br />
vast, complex and delicately balanced<br />
ecosystem comprising bacteria, fungi and<br />
viruses.<br />
The intestinal microbiome plays an<br />
important role in human health by preventing<br />
infection, contributing to normal<br />
immune function and influencing metabolism.<br />
Disruption <strong>of</strong> this ecosystem may<br />
lead to abnormal immune and metabolic<br />
responses that are hypothesized to be<br />
involved in the development <strong>of</strong> NAFLD.<br />
The goal <strong>of</strong> this study is to investigate<br />
the composition <strong>of</strong> the intestinal<br />
microbiome in obese pediatric patients<br />
with and without NAFLD to determine<br />
whether differences in their intestinal<br />
bacteria could relate to the development<br />
<strong>of</strong> fatty liver and liver inflammation in<br />
children. Understanding how changes in<br />
the microbiome affect the progression <strong>of</strong><br />
NAFLD may lead to new methods <strong>of</strong> predicting<br />
the disease and novel interventions<br />
using prebiotics, probiotics or<br />
antibiotics to manipulate the microbiome<br />
for prevention or treatment.<br />
Braza appointed Chair <strong>of</strong> PM&R<br />
Diane W. Braza, MD ’87, GME<br />
’93, Associate Pr<strong>of</strong>essor <strong>of</strong> Physical<br />
Medicine and Rehabilitation<br />
and Associate<br />
Pr<strong>of</strong>essor <strong>of</strong><br />
Neurosurgery at the<br />
<strong>Medical</strong> <strong>College</strong> <strong>of</strong><br />
<strong>Wisconsin</strong> (MCW),<br />
has been named<br />
Chair <strong>of</strong> Physical<br />
Medicine and Rehabilitation after a<br />
national review. Dr. Braza is the physical<br />
medicine and rehabilitation residency<br />
program director and had been serving as<br />
interim chair <strong>of</strong> the department since<br />
October 2011. Prior to assuming the role<br />
<strong>of</strong> interim chair, she served as <strong>Medical</strong><br />
Director <strong>of</strong> Froedtert & The <strong>Medical</strong> <strong>College</strong><br />
<strong>of</strong> <strong>Wisconsin</strong> SpineCare Program.<br />
Dr. Braza practices at Froedtert Hospital.<br />
She oversees MCW’s physical<br />
medicine and rehabilitation programs at<br />
Froedtert, the Zablocki VA <strong>Medical</strong> Center<br />
and Children’s Hospital <strong>of</strong> <strong>Wisconsin</strong>.<br />
She joined the MCW faculty in 1992.<br />
Alumnus named to new endowed hematology chair<br />
Parameswaran Hari, MD, Fel ’04,<br />
MS ’06, Associate Pr<strong>of</strong>essor <strong>of</strong> Medicine<br />
(Hematology and<br />
Oncology), has<br />
been named the<br />
first Armand J.<br />
Quick/William F.<br />
Stapp Pr<strong>of</strong>essor in<br />
Hematology at<br />
MCW. Dr. Hari is<br />
an internationally renowned researcher in<br />
multiple myeloma, and serves as director<br />
<strong>of</strong> the adult Blood and Marrow Transplant<br />
Program at Froedtert Hospital. He<br />
is also the scientific director for the<br />
plasma cells disorder working committee<br />
at the Center for International Blood and<br />
Marrow Transplant Research.<br />
The Armand J. Quick/William F.<br />
Stapp Pr<strong>of</strong>essorship was established this<br />
year by MCW from an endowment provided<br />
by the late William F. Stapp, MD<br />
’51, and his family to honor the memory<br />
<strong>of</strong> Armand J. Quick, MD, and to provide<br />
support to a leader in hematology<br />
research and practice.<br />
The late Dr. Quick was Chairman <strong>of</strong><br />
Biochemistry at Marquette University<br />
School <strong>of</strong> Medicine (MCW’s predecessor)<br />
from 1944-1964. His research in the<br />
fields <strong>of</strong> blood clotting and the diagnosis<br />
and treatment <strong>of</strong> bleeding disorders<br />
brought him international recognition.<br />
He is best known for developing the<br />
“Quick Prothrombin Time,” a clinical<br />
blood test to diagnose bleeding disorders<br />
and monitor dosage <strong>of</strong> anticoagulation<br />
therapy that was a critical driver <strong>of</strong><br />
research in the field and is still used<br />
widely.<br />
Like our page on Facebook<br />
facebook.com/medicalcollege<strong>of</strong>wisconsin<br />
ALUMNI NEWS <strong>Spring</strong> <strong>2013</strong> 5